Hudson Bay Capital Management’s Sage Therapeutics SAGE Stock Holding History

Hudson Bay Capital Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,952,245	Closed	-$17.8M	–	1626
2025 Q2	$17.8M	Buy	1,952,245 +1,372,672	+237%	+$10.1M	0.06%	237
2025 Q1	$4.61M	Buy	579,573 +332,573	+135%	+$2.44M	0.01%	613
2024 Q4	$1.34M	Sell	247,000 -98,000	-28%	-$599K	﹤0.01%	713
2024 Q3	$2.49M	Buy	345,000 +54,300	+19%	+$497K	0.01%	542
2024 Q2	$3.16M	Sell	290,700 -84,300	-22%	-$1.08M	0.01%	465
2024 Q1	$7.03M	Sell	375,000 -20,000	-5%	-$461K	0.04%	233
2023 Q4	$8.56M	Buy	395,000 +120,000	+44%	+$2.38M	0.05%	207
2023 Q3	$5.66M	Buy	275,000 +260,000	+1,733%	+$7.51M	0.04%	256
2023 Q2	$705K	Sell	15,000 -65,000	-81%	-$3.23M	0.01%	617
2023 Q1	$3.36M	Sell	80,000 -210,000	-72%	-$9.03M	0.03%	405
2022 Q4	$11.1M	Sell	290,000 -5,000	-2%	-$191K	0.11%	155
2022 Q3	$11.6M	Hold	295,000	–	–	0.1%	137
2022 Q2	$9.53M	Buy	295,000 +250,000	+556%	+$8.38M	0.07%	207
2022 Q1	$1.49M	Sell	45,000 -5,000	-10%	-$188K	0.02%	762
2021 Q4	$2.13M	Buy	50,000 +25,000	+100%	+$1.05M	0.02%	659
2021 Q3	$1.11M	Buy	+25,000	New	+$1.15M	0.02%	727
2020 Q3	–	Sell	-150,000	Closed	-$6.24M	–	620
2020 Q2	$6.24M	Buy	150,000 +60,000	+67%	+$2.18M	0.11%	170
2020 Q1	$2.58M	Buy	+90,000	New	+$5.21M	0.06%	236
2019 Q4	–	Sell	-10,000	Closed	-$1.23M	–	499
2019 Q3	$1.4M	Hold	10,000	–	–	0.04%	287
2019 Q2	$1.83M	Sell	10,000 -10,000	-50%	-$1.71M	0.04%	287
2019 Q1	$3.18M	Hold	20,000	–	–	0.04%	374
2018 Q4	$1.92M	Buy	+20,000	New	+$2.29M	0.03%	518
2017 Q4	–	Sell	-10,000	Closed	-$623K	–	540
2017 Q3	$623K	Buy	+10,000	New	+$785K	0.02%	323

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hudson Bay Capital Management's SAGE Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 1,952,245 shares — an estimated $17.8M sold.

Hudson Bay Capital Management first reported a position in SAGE in Q3 2017 and held it in 23 quarters. The position peaked at $17.8M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

Hudson Bay Capital Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
Hudson Bay Capital Management sold 1,952,245 Sage Therapeutics shares in Q3 2025, an estimated $17.8M.
Hudson Bay Capital Management first reported a position in Sage Therapeutics in Q3 2017 and held it in 23 quarters.
Hudson Bay Capital Management's Sage Therapeutics position peaked at $17.8M in Q2 2025.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.